These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 17476349)

  • 1. DC-based cancer vaccines.
    Gilboa E
    J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells: tools and targets for antitumor vaccination.
    den Brok MH; Nierkens S; Figdor CG; Ruers TJ; Adema GJ
    Expert Rev Vaccines; 2005 Oct; 4(5):699-710. PubMed ID: 16221071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA transfected dendritic cells as cancer vaccines.
    Mitchell DA; Nair SK
    Curr Opin Mol Ther; 2000 Apr; 2(2):176-81. PubMed ID: 11249639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of dendritic cells in cancer immunotherapy.
    Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A; Brossart P
    Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DC in multiple myeloma immunotherapy.
    Turtle CJ; Brown RD; Joshua DE; Hart DN
    Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-based cancer vaccination: quo vadis?
    Dauer M; Schnurr M; Eigler A
    Expert Rev Vaccines; 2008 Sep; 7(7):1041-53. PubMed ID: 18767953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K; Wang L; Zhang Y
    Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based vaccines in breast and gynaecologic cancer.
    Hernando JJ; Park TW; Kuhn WC
    Anticancer Res; 2003; 23(5b):4293-303. PubMed ID: 14666641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration of dendritic cell based cancer vaccines: in vivo veritas?
    Adema GJ; de Vries IJ; Punt CJ; Figdor CG
    Curr Opin Immunol; 2005 Apr; 17(2):170-4. PubMed ID: 15766677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response to breast cancer, and the case for DC immunotherapy.
    Allan CP; Turtle CJ; Mainwaring PN; Pyke C; Hart DN
    Cytotherapy; 2004; 6(2):154-63. PubMed ID: 15203992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of whole tumor lysate into dendritic cells for cancer vaccination.
    Liu LN; Shivakumar R; Allen C; Fratantoni JC
    Methods Mol Biol; 2008; 423():139-53. PubMed ID: 18370195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues in delivering DCs for immunotherapy.
    Barratt-Boyes SM; Figdor CG
    Cytotherapy; 2004; 6(2):105-10. PubMed ID: 15203986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.